Is NGL Fine-Chem a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that NGL Fine-Chem Ltd is a average quality company .

Is NGL Fine-Chem undervalued or overvalued?

The key valuation ratios of NGL Fine-Chem Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is NGL Fine-Chem share price return in the past 10 years?

NGL Fine-Chem Ltd share price has appreciated 36.6% annually (CAGR) over the past ten years.

Is NGL Fine-Chem a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of NGL Fine-Chem Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

NGL Fine-Chem Ltd - Stock Valuation and Financial Performance

Name: NGL Fine-Chem
Brand: NGL Fine-Chem

BSE: 524774 | NSE: NGLFINE | Pharmaceuticals & Drugs | Small Cap

Place order

NGL Fine-Chem Share Price

₹1,905.50 -57.40 -2.92%
as on 24-Dec'24 16:59

10 Year X-Ray of NGL Fine-Chem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	33%	37.1%	33.8%	21.7%	27.6%	13.7%	51.9%	34.7%	11.5%	18.9%	-
Value Creation Index ⓘ	1.4	1.7	1.4	0.6	1.0	0.0	2.7	1.5	-0.2	0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	88.3	96.3	99.7	114	153	152	258	319	275	329	348
Sales YoY Gr.	-	9%	3.6%	14%	34.8%	-0.7%	69.7%	23.4%	-13.7%	19.6%	-
Adj EPS ⓘ	11.3	18.5	22.9	18.6	29	16.6	88.1	84.6	29.4	58.4	62.4
YoY Gr.	-	63.1%	24.2%	-18.9%	56%	-42.7%	430%	-4%	-65.2%	98.4%	-
BVPS (₹) ⓘ	53.1	71.6	96.2	116.6	149.1	163.8	251.6	334.4	365	425.4	438.1
Adj Net Profit ⓘ	7	11.4	14.2	11.5	17.9	10.3	54.5	52.3	18.2	36.1	39
Cash Flow from Ops. ⓘ	7.5	8.4	9.9	22.4	8.9	19.6	26.6	15.8	31.9	11.1	-
Debt/CF from Ops. ⓘ	1.8	1.7	2.3	1.2	3.1	1.4	0.6	1.9	1	3.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	15.7%	16.5%	8.4%	19.6%
Adj EPS ⓘ	20%	15%	-12.8%	98.4%
BVPSⓘ	26%	23.3%	19.1%	16.5%
Share Price	36.6%	35%	-9.2%	-2.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	24.4	29.6	27.3	17.5	21.8	10.6	42.4	28.9	8.4	14.8	14.5
Op. Profit Mgn % ⓘ	16.9	22.8	25.6	19	21.1	15.2	29.8	20.7	10.4	13.6	12.4
Net Profit Mgn % ⓘ	7.9	11.8	14.2	10.1	11.7	6.8	21.1	16.4	6.6	11	11.1
Debt to Equity ⓘ	0.4	0.3	0.4	0.4	0.3	0.3	0.1	0.2	0.1	0.1	-
Working Cap Days ⓘ	152	160	187	198	167	184	132	166	216	186	101
Cash Conv. Cycle ⓘ	65	74	81	65	55	79	49	74	99	76	61

Recent Performance Summary

Sales growth is good in last 4 quarters at 25.57%

Return on Equity has declined versus last 3 years average to 14.40%

Sales growth has been subdued in last 3 years 8.41%

Net Profit has been subdued in last 3 years -12.82%

Latest Financials - NGL Fine-Chem Ltd.

	Standalone	Consolidated
TTM EPS (₹)	62.4	67
TTM Sales (₹ Cr.)	348	372
BVPS (₹.) ⓘ	438.1	453.7
Reserves (₹ Cr.) ⓘ	268	277
P/BV ⓘ	4.35	4.20
PE ⓘ	30.54	28.44

From the Market
52 Week Low / High (₹)	1728.60 / 2822.50
All Time Low / High (₹)	0.40 / 3789.45
Market Cap (₹ Cr.)	1,177
Equity (₹ Cr.)	3.1
Face Value (₹)	5
Industry PE ⓘ	44.4

Management X-Ray of NGL Fine-Chem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of NGL Fine-Chem

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of NGL Fine-Chem

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	88	96	100	114	153	152	258	319	275	329
Operating Expenses ⓘ	73	74	74	92	121	131	181	253	246	284
Manufacturing Costs	13	13	15	18	22	27	33	50	50	63
Material Costs	42	41	38	46	63	65	103	148	140	155
Employee Cost	9	11	14	18	21	24	27	33	34	41
Other Costs ⓘ	9	10	8	10	15	16	19	22	23	25
Operating Profit ⓘ	15	22	25	22	32	21	77	66	29	45
Operating Profit Margin (%)	16.9%	22.8%	25.5%	19.0%	21.1%	13.7%	29.8%	20.7%	10.4%	13.6%
Other Income ⓘ	0	0	1	3	4	3	9	13	8	16
Interest ⓘ	2	2	1	2	3	3	2	2	2	2
Depreciation ⓘ	3	3	3	5	6	7	7	8	8	8
Exceptional Items ⓘ	2	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	13	18	23	18	28	14	76	69	27	51
Tax ⓘ	5	6	8	5	7	4	21	17	6	12
Profit After Tax	8	11	15	13	20	11	55	52	20	39
PAT Margin (%)	9.4%	11.8%	14.9%	11.1%	13.1%	7.0%	21.5%	16.4%	7.3%	11.7%
Adjusted EPS (₹)	13.5	18.5	24.1	20.5	32.6	17.2	89.8	84.6	32.6	62.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	5%	10%	2%	2%	5%	3%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	33	44	59	72	92	101	155	207	226	263
Share Capital ⓘ	3	3	3	3	3	3	3	3	3	3
Reserves ⓘ	30	41	56	69	89	98	152	203	222	260
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	11	13	20	24	23	23	11	27	30	32
Long Term Debt	2	0	9	12	8	8	6	3	2	1
Short Term Debt	10	12	11	11	15	15	5	23	28	32
Trade Payables	17	14	14	24	16	21	27	35	23	47
Others Liabilities ⓘ	5	7	17	14	18	11	12	10	9	11
Total Liabilities ⓘ	67	78	111	133	149	156	206	278	288	353
Fixed Assets
Gross Block	29	38	28	64	74	81	85	92	100	108
Accumulated Depreciation	11	13	3	7	13	20	27	33	41	48
Net Fixed Assetsⓘ	17	24	25	56	61	61	58	59	59	60
CWIP ⓘ	1	2	16	3	0	0	1	6	26	46
Investmentsⓘ	2	3	6	6	9	14	33	32	43	57
Inventories	12	10	12	17	19	28	38	55	27	43
Trade Receivables	26	32	30	28	33	26	38	65	65	83
Cash Equivalents	2	2	2	4	3	3	5	1	13	2
Others Assetsⓘ	6	4	20	19	25	23	34	60	54	63
Total Assets ⓘ	67	78	111	133	149	156	206	278	288	353

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	8	8	10	22	9	20	27	16	32	11
PBT ⓘ	13	18	23	18	28	14	76	69	27	51
Adjustment ⓘ	3	3	3	5	8	11	3	7	6	-1
Changes in Working Capital ⓘ	-4	-6	-8	4	-19	-2	-32	-43	6	-26
Tax Paid ⓘ	-5	-6	-8	-5	-7	-4	-21	-17	-6	-12
Cash Flow From Investing Activity ⓘ	-3	-10	-10	-21	-10	-19	-24	-16	-24	-17
Capex	-3	-10	-18	-23	-14	-7	-5	-14	-29	-28
Net Investments	0	0	1	0	0	-4	1	0	0	0
Others ⓘ	0	0	7	2	5	-8	-20	-2	5	11
Cash Flow From Financing Activityⓘ	-4	2	0	0	0	-1	-1	-1	-1	-1
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-2	-1	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	-1	-1	-1	-1	-1
Others ⓘ	-2	3	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	1	0	0	1	-1	0	2	-1	7	-7

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	29.04	29.59	28.73	19.22	24.52	10.97	43.22	28.86	9.31	15.78
ROCE (%)	33.03	37.14	33.8	21.68	27.63	13.65	51.9	34.71	11.5	18.93
Asset Turnover Ratio	1.57	1.44	1.13	0.95	1.08	1	1.43	1.32	0.97	1.03
PAT to CFO Conversion(x)	1	0.73	0.67	1.69	0.45	1.82	0.49	0.31	1.6	0.28
Working Capital Days
Receivable Days	95	103	107	91	72	71	45	59	86	82
Inventory Days	39	39	37	45	42	56	46	53	54	39
Payable Days	119	123	123	145	111	97	74	65	71	83

NGL Fine-Chem Ltd Stock News

NGL Fine-Chem Ltd FAQs

What is the share price of NGL Fine-Chem?

Company share prices are keep on changing according to the market conditions. The closing price of NGL Fine-Chem on 24-Dec-2024 16:59 is ₹1,905.5.

What is the market cap of NGL Fine-Chem?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Dec-2024 16:59 the market cap of NGL Fine-Chem stood at ₹1,177.2.

What is the P/E ratio of NGL Fine-Chem?

The latest P/E ratio of NGL Fine-Chem as of 24-Dec-2024 16:59 is 30.54.

What is the P/B ratio of NGL Fine-Chem?

The latest P/B ratio of NGL Fine-Chem as of 24-Dec-2024 16:59 is 4.35.

What is the 52-week high and low of NGL Fine-Chem?

The 52-week high of NGL Fine-Chem is ₹2,822.5 and the 52-week low is ₹1,728.6.

What is the TTM revenue of NGL Fine-Chem?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of NGL Fine-Chem is ₹347.9 ( Cr.) .

About NGL Fine-Chem Ltd

NGL Fine-chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility.

Its business is modelled around the changing customer demands and their ability to offer value-added innovative solutions to meet and even exceed these demands.

Utilizing its expertise in complex multi-stage organic synthesis, it continues to expand the product portfolio with new products.

It has established a strong presence in global pharmaceutical companies with its commitment to competitive prices, delivery schedules, international quality standards and constant technological upgradation.

NGL Fine-chem Ltd has a strong focus on developing intellectual property as a key differentiator and as a platform for further growth up the pharma value chain. It respect intellectual property and invest in developing it as a key growth driver for the future.

Product range of the company includes:

Pharmaceutical like Diminazene Aceturate, Diminazene Diaceturate, Homidium Chloride, Nitroxynil, Clorsulon, Homidium Bromide, Parvaquone, Carprofen, Buparvaquone and Isometamidium Chloride Hydrochloride for:

Animal health
Human health
Intermediate- 4 Aminobenzamidine Dihydrochloride, 3 Aminobenzamidine Dihydrochloride, Ezetimibe Intermediates etc
Finished dosages form- Homidium Chloride Tablets, Diminazene Aceturate Granules

Achievements/ recognition

An ISO 9001:2000 accredited company